OUR PRODUCTS

250 mg film-coated tablets

(ivosidenib)

To read the most recent version of the Summary of Product Characteristics (SmPC) and Patient Information Leaflet (PIL), click below:

2.5 mg and 5 mg and 10 mg

(perindopril arginine)

To read the most recent version of the Summary of Product Characteristics (SmPC) and Patient Information Leaflet (PIL), click below:

5 mg /1.25 mg

(perindopril arginine and indapamide)

To read the most recent version of the Summary of Product Characteristics (SmPC) and Patient Information Leaflet (PIL), click below:

30 mg

(gliclazide)

To read the most recent version of the Summary of Product Characteristics (SmPC) and Patient Information Leaflet (PIL), click below:

15 mg/6.14 mg and 20 mg/8.19 mg

(trifluridine and tipiracil hydrochloride)

To read the most recent version of the Summary of Product Characteristics (SmPC) and Patient Information Leaflet (PIL), click below:

2.5 mg

(indapamide)

To read the most recent version of the Summary of Product Characteristics (SmPC) and Patient Information Leaflet (PIL), click below:

1.5 mg

(Indapamide)

To read the most recent version of the Summary of Product Characteristics (SmPC) and Patient Information Leaflet (PIL), click below:

750 U/ml powder for solution for injection/infusion

(pegaspargase)

To read the most recent version of the Summary of Product Characteristics (SmPC) and Patient Information Leaflet (PIL), click below:

4.3 mg/ml concentrate for dispersion for infusion

(irinotecan sucrosofate)

To read the most recent version of the Summary of Product Characteristics (SmPC) and Patient Information Leaflet (PIL), click below:

5 mg and 7.5 mg

(ivabradine)

To read the most recent version of the Summary of Product Characteristics (SmPC) and Patient Information Leaflet (PIL), click below:

25 mg

(agomelatine)

To read the most recent version of the Summary of Product Characteristics (SmPC) and Patient Information Leaflet (PIL), click below: